The UPMC Immune Transplant and Therapy Center\nUPMC and the University of Pittsburgh are once again partnering to revolutionize the world of medicine. A bold and ambitious collaboration, the UPMC Immune Transplant and Therapy Center will change the way the world thinks about \u2013 and treats \u2013 a variety of diseases and conditions.\nAs part of this endeavor, UPMC will invest $200 million in the development of the UPMC Immune Transplant and Therapy Center. The University of Pittsburgh will transform a century-old building into an eight-story innovation hub.\nThis collaboration is all part of a concerted effort to harness the power of the human immune system to treat and cure a wide range of diseases.\nBacked by decades of pioneering research at the University of Pittsburgh, UPMC\u2019s commitment to the Immune Transplant and Therapy Center seeks to dramatically accelerate the pace at which medical teams can utilize new research. This investment will help pinpoint the most promising advances in immunology that are capable of enhancing human health. The center\u2019s work will initially focus on three major areas: transplantation, cancer, and chronic diseases of aging.\nTo learn more about the UPMC Immune Transplant and Therapy Center, visit UPMC.com\/ITTC.\n\n\n\n\nWhat Is Immunotherapy?\nImmunotherapy is the treatment of a disease by inducing, enhancing, or suppressing an immune response. With the establishment of the UPMC Immune Transplant and Therapy Center, we\u2019ve brought our brightest minds in immunotherapy research together in the areas of organ transplantation, cancer, and chronic diseases of aging.\nTransplant\nFor more than 30 years, UPMC has been a leader in the field of transplantation. We are now setting our sights on a new frontier – immune transplantation. Currently, all transplant recipients need to take life-long anti-rejection medication following a transplant. Our research will reduce, or possibly eliminate, the need for immunosuppression.\nCancer\nTogether UPMC and the University of Pittsburgh set the course for cancer immunotherapy. With the development of the UPMC Immune Transplant and Therapy Center, we are taking our research to the next level. By fine-tuning the immune system, we can leverage the body\u2019s own defenses to fight cancer, helping us to not only extend a patient\u2019s life but also improve its quality.\nChronic Diseases of Aging\nAs one of the biggest mysteries in the field of medicine, experts at the UPMC Immune Transplant and Therapy Center will discover uncharted territory in the field of aging research. By exploring the basic biology of aging, we can develop better treatment and prevention strategies for age-related conditions.\nCreating the Future of Medicine\nImmunotherapy is not new. Experts at the UPMC Hillman Cancer Center have been on the forefront of novel immunotherapy approaches to cancer treatment for years. And, UPMC\u2019s early leadership in transplant and its longstanding transplantation program have allowed its researchers the opportunity to study the science of engineering patients\u2019 immune systems so they will treat donor organs as their own. However, now is the time to propel our success forward, increase the speed of discovery, and unlock the power of the human immune system.\nTo learn more about the UPMC Immune Transplant and Therapy Center, visit UPMC.com\/ITTC.